Search filters

List of works by Janet R Wade

A guide for reporting the results of population pharmacokinetic analyses: a Swedish perspective

scientific article

A population model for the follicular growth in women treated with follicle stimulating hormone

scientific article published on December 1, 1997

A receptor theory-based semimechanistic PD model for the CCR5 noncompetitive antagonist maraviroc.

scientific article published in April 2008

Assessment of Maraviroc Exposure-Response Relationship at 48 Weeks in Treatment-Experienced HIV-1-Infected Patients in the MOTIVATE Studies.

scientific article published on 14 August 2013

Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients.

scientific article

Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset Seizures.

scientific article published on 5 May 2016

Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.

scientific article

Discrimination between rival dosing histories.

scientific article published in August 1997

Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis

scientific article published on 01 April 1993

Evaluation of brivaracetam efficacy as monotherapy in adult patients with focal seizures.

scientific article published on 20 September 2017

Evaluation of the effects of the weak CYP3A inhibitors atorvastatin and ethinyl estradiol/norgestimate on lomitapide pharmacokinetics in healthy subjects

scientific article published on 10 September 2015

Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal Seizures.

scientific article published on 7 September 2017

Felodipine population dose-response and concentration-response relationships in patients with essential hypertension.

scientific article published on May 1995

Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis.

scientific article published in April 1994

Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group

scientific article published on 2 February 2016

Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse-transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patients.

scientific article published on 29 September 2010

Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease.

scientific article published on 13 April 2015

Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic colorectal cancer and other solid tumors

scientific article published on 02 November 2019

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin.

scientific article published in December 2006

The effect of saturation of ACE binding sites on the pharmacokinetics of enalaprilat in man

scientific article published on February 1, 1992

The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women.

scientific article

Variability in the pharmacokinetics of epirubicin: a population analysis

scientific article published on 01 January 1992